Successful Treatment of Large B-Cell Lymphoma in a Child with Compound Heterozygous Mutation in the ATM Gene
Authors:
- Jakub CzarnyJCJakub Czarny
- Marta AndrzejewskaMAMarta Andrzejewska
- Olga Zając-SpychałaOZOlga Zając-Spychała
- Elżbieta Latos-GrażyńskaELElżbieta Latos-Grażyńska
- Agata PastorczakAPAgata Pastorczak
- Kamila WypyszczakKWKamila Wypyszczak
- Aleksandra Szczawińska-PopłonykAleksandra Szczawińska-Popłonyk
- Izabela Niewiadomska-WojnałowiczINIzabela Niewiadomska-Wojnałowicz
- Agnieszka WziątekAWAgnieszka Wziątek
- Patrycja Marciniak-StępakPMPatrycja Marciniak-Stępak
- Michał DopierałaMDMichał Dopierała
- Jadwiga MałdykJMJadwiga Małdyk
Open Access
- 6 January 2023
- journal article
- case report
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 24 (2) , 1099
Abstract
Ataxia-telangiectasia (AT) is a multisystemic neurodegenerative inborn error of immunity (IEI) characterized by DNA repair defect, chromosomal instability, and hypersensitivity to ionizing radiation. Impaired DNA double-strand break repair determines a high risk of developing hematological malignancies, especially lymphoproliferative diseases. Poor response to treatment, excessive chemotherapy toxicities, and the need for avoiding exposure to ionizing radiation make the successful clinical management of patients with AT challenging for oncologists. We describe the favorable outcome of the LBCL with IRF4 rearrangement at stage III in a 7-year-old female patient diagnosed with AT. The patient was treated according to the B-HR arm of the INTER-B-NHL-COP 2010 protocol, including the administration of rituximab, cyclophosphamide, methotrexate, prednisone, etc. She presented excessive treatment toxicities despite individually reduced doses of methotrexate and cyclophosphamide. However, in the MRI there was no significant reduction in pathologic lymph nodes after three immunochemotherapy courses. Therefore, a lymph node biopsy was taken. Its subsequent histopathological examination revealed tuberculosis-like changes, though tuberculosis suspicion was excluded. After two following immunochemotherapy courses, PET-CT confirmed complete remission. From March 2022 onwards, the patient has remained in remission under the care of the outpatient children’s oncology clinic.Keywords
This publication has 33 references indexed in Scilit:
- Understanding MYC-driven aggressive B-cell lymphomas: pathogenesis and classificationHematology-American Society Hematology Education Program, 2013
- The Human Gene Mutation Database: building a comprehensive mutation repository for clinical and molecular genetics, diagnostic testing and personalized genomic medicineHuman Genetics, 2013
- The role ofATMmutations and 11q deletions in disease progression in chronic lymphocytic leukemiaLeukemia & Lymphoma, 2013
- Follicular Lymphomas in Children and Young AdultsAmerican Journal of Surgical Pathology, 2013
- Integrative genomics viewerNature Biotechnology, 2011
- A method and server for predicting damaging missense mutationsNature Methods, 2010
- Fast and accurate long-read alignment with Burrows–Wheeler transformBioinformatics, 2010
- Mendelian Inheritance in Man and Its Online Version, OMIMThe American Journal of Human Genetics, 2007
- ATM Gene Founder Haplotypes and Associated Mutations in Polish Families with Ataxia‐TelangiectasiaAnnals of Human Genetics, 2005
- A late onset variant of ataxia-telangiectasia with a compound heterozygous genotype, A8030G/7481insAJournal of Medical Genetics, 2002